NEW YORK, Sept. 16 (GenomeWeb News) - Sagres Discovery today said it has signed a cancer research collaboration with the Genome Institute of Singapore (GIS).
GIS will use gene-expression profiling and bioinformatics to characterize a collection of Sagres' proprietary provirus-tagged mouse tumors. GIS and Sagres said they would compare the gene-expression data with expression profiles of human cancers in order to map the genetic interaction pathways of the Oncogenome - a list of cancer-causing genes that Sagres has identified.
Sagres said it would have the option to obtain from GIS exclusive rights to novel genes and pathways identified during the collaboration, with commercial terms to be agreed separately. GIS will retain the right to use the results for its non-commercial research and development.